Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prediction models are increasingly used to complement clinical reasoning and decision making in modern medicine in general, and in the cardiovascular domain in particular. Developed models first and foremost need to provide accurate and (internally and externally) validated estimates of probabilities of specific health conditions or outcomes in targeted patients. The adoption of such models must guide physician's decision making and an individual's behaviour, and consequently improve individual outcomes and the cost-effectiveness of care. In a series of two articles we review the consecutive steps generally advocated for risk prediction model research. This first article focuses on the different aspects of model development studies, from design to reporting, how to estimate a model's predictive performance and the potential optimism in these estimates using internal validation techniques, and how to quantify the added or incremental value of new predictors or biomarkers (of whatever type) to existing predictors. Each step is illustrated with empirical examples from the cardiovascular field.

Original publication

DOI

10.1136/heartjnl-2011-301246

Type

Journal article

Journal

Heart (British Cardiac Society)

Publication Date

05/2012

Volume

98

Pages

683 - 690

Addresses

Julius Center for Health Sciences and Primary Care, UMC Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. k.g.m.moons@umcutrecht.nl

Keywords

Humans, Cardiovascular Diseases, Biological Markers, Risk, Reproducibility of Results, Predictive Value of Tests, Decision Making, Decision Support Techniques, Models, Theoretical, Cost-Benefit Analysis